News
-
Changes to the Guidance document Time limits for authorisation applications
-
Changes to the Guidance document Temporary authorisation of human medicinal products
-
Changes to the Guidance document Meetings for applicants for authorisation procedures
-
Changes to the Guidance document Variations and extensions HAM
-
Swiss Public Assessment Report (SwissPAR)
-
Decision C-3747/2021 of 15 May 2024
-
Decision C-890/2024 of 28 May 2024
-
Decision 9C_360/2023 of 10 April 2024
-
Swissmedic Vigilance-News Edition 32 – May 2024
-
Swissmedic magazine "Visible" Edition 9/2024
-
Annual report highlights progress in science, medicines and health in 2023
-
Federal Council approves collective agreement for inpatient psychiatry
-
Federal Council approves quality contract between H+, santésuisse and curafutura
-
Publication with Swissmedic involvement on the risk assessment of nitrosamine impurities
-
Regulatory & Beyond 2024 – Save the Date
-
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 May 2024
-
Medical devices: new guidance for industry and notified bodies
-
Decision C-2364/2021 of 24 April 2024
-
Decision A-1004/2023 of 7 May 2024
-
Women's health needs require more thorough consideration
-
Federal Council wants to improve working conditions and education for nursing professionals